Followers | 37 |
Posts | 6014 |
Boards Moderated | 1 |
Alias Born | 08/07/2018 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, February 16, 2019 3:48:51 PM
submission in regards to RecoveryRX is different in that it has a predicate for post op healing with the FDA's
previous approval for blepharoplasty. When clearance is given on one or both 510k applications you will see a
corresponding hike in the pps. Then I think it BIEL would be a very attractive acquisition for a large medical device company. What would the pps be then ? hmmmm
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM